Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease

Circulation. 2023 Mar 7;147(10):795-797. doi: 10.1161/CIRCULATIONAHA.122.063195. Epub 2023 Mar 6.
No abstract available

Keywords: Editorials; atrial fibrillation; chronic liver disease; direct-acting oral anticoagulants.

Publication types

  • Editorial

MeSH terms

  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Factor Xa Inhibitors / adverse effects
  • Humans
  • Liver Diseases* / complications
  • Liver Diseases* / drug therapy
  • Patients

Substances

  • Factor Xa Inhibitors